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Schools are a logical place to promote adherence among children. 17 With an average minimum of 180 school days per year, 18 schools provide an opportunity to help children establish good health habits, especially for chronic conditions that require regular treatment regimens. Furthermore, asthma morbidity is seasonal, with the greatest number of exacerbations occurring during the school year. [19] [20] [21] Three previous studies suggested that supervised therapy at school improved asthma outcomes. [22] [23] [24] Two small studies indicated that school-based delivery of steroids improved asthma control 23, 24 ; however, both studies had small sample sizes and short follow-up periods. A larger study of 180 children indicated that school-based supervision of inhaled steroid treatment improved asthma symptoms but only among children who were not exposed to secondhand smoke. 22 This article describes a randomized trial of the effectiveness of school-based supervised asthma therapy in improving asthma control.
METHODS

Participants
Children with physician-diagnosed persistent asthma and the need for daily controller medication who were enrolled in 1 of 36 participating schools and who had the ability to use a dry-powder inhaler and a peak flowmeter (PFM) were enrolled. Children were given the same inhaled corticosteroid and were excluded if their physicians considered it inappropriate to change their prescriptions to budesonide inhalation powder. Children were recruited through local schools, physician offices, and health departments. Parents provided written informed consent; children provided assent. The University of Alabama at Birmingham institutional review board and an independent data safety monitoring board approved and monitored the study.
At enrollment, children were assessed by a physician (the child's primary care provider or, if no primary care provider was identified, the study physician), and budesonide inhalation powder, in a single daily dose specific to each child's need (1-4 puffs), was prescribed. [25] [26] [27] [28] [29] [30] [31] Inhaled steroids and rescue medication were provided at no cost. Refills were supplied by mail at telephone request. Children were also provided with an asthma action plan and 2 PFMs (1 for home and 1 for school). Children could take additional asthma medications if their physicians considered them warranted; use of those medications was not supervised by study staff members.
Study Design
By using a 2-group, randomized, longitudinal design with a 15-month follow-up period, children were randomly assigned to school-based, supervised, asthma therapy or usual care (parent-supervised asthma therapy). After enrollment by study staff members, children were assigned an identification number corresponding to their school. A random sequence of treatment codes, stratified according to school system, was generated by the statistician with SAS 9.1 (SAS Institute, Inc, Cary, NC).
Intervention
For children assigned randomly to the supervised-therapy arm, the use of inhaled corticosteroids was supervised by study staff members at school each day. A standard daily time was arranged with each school, during which staff members observed children taking their medication. If a child arrived later in the day, then study staff members returned to the school to supervise medication use. If a child was observed to be using the inhaler incorrectly, then staff members provided education with the aid of a placebo inhaler. Children assigned randomly to usual care continued their usual parent-or self-supervised use of daily inhaled corticosteroid treatment at home.
Data Collection
Baseline data collection occurred from October 2005 to December 2005. In January 2006, children were randomly assigned to either supervised therapy or usual care. Randomization occurred at the individual student level within each school system to account for factors that differed across school systems. Follow-up data were collected from January 2006 to December 2006, in the same manner as baseline data. To avoid differences in the frequency of episodes of poor asthma control (EPACs) attributable to seasonal variation, the main comparison used the data from October through December in both school years. 20, 21 Data on daily PFM readings, rescue medication use, and school absences were collected at school for all children. Previous experience indicated that daily data collection is difficult to achieve without interrupting school schedules. 32 To minimize these interruptions, investigators collaborated with BlueCross BlueShield of Alabama to develop an Internet-based data-collection system (Asthma Agents system). A detailed description of this system has been published. 33 PFM readings were based on the values representing the child's best peak flow meter reading during healthy periods at the beginning of each school year. Red readings indicated peak flow rates Յ50% of the best value, yellow readings indicated peak flow rates 50% to 80% of the best value, and green readings indicated peak flow rates Ͼ80% of the best value. School staff members were trained to have children log on to the Asthma Agents system at the same time each day, to prevent diurnal variations in PFM readings. Designated school staff members also logged on to the system, to verify PFM readings and to report on child absences.
At-school rescue medication use was monitored by using a Doser device (Meditrack, Hudson, MA) attached to the top of the inhaler, which activated automatically to record each inhalation taken. Study staff members read each child's Doser every 2 weeks, to record usage. No data were collected on rescue medication or inhaled steroid use at home either on weekends or during school breaks. Because children spend the majority of their time at school during the seasons when asthma symptoms are most common, 18, 20 the cost and effort of collecting data at home were considered excessive in relation to the return. Data on health care utilization, secondhand smoke exposure, and quality of life were collected at the beginning of each school year and at the end of the study, through telephone interviews with parents. Secondhand smoke exposure status was assessed by using the following 2 questions. (1) "Are there smokers in the house where your child lives?" (2) "Are there smokers in other places where your child spends a lot of time, such as a day care or a friend's house?" Smoke exposure was grouped into 3 categories (ie, no secondhand smoke exposure, secondhand smoke exposure outside the primary household only, or secondhand smoke exposure inside the primary household). Quality of life was assessed by using the Juniper Pediatric Asthma Caregiver Quality of Life Questionnaire. 34 Asthma safety events were monitored by the data safety monitoring board, with daily data from the Internet-based collection system (asthma symptoms and PFM readings). In addition, teachers and parents were asked to report adverse events throughout the study period. Study staff members had weekly contact with teachers and reminded them to report adverse events related to the study drug (eg, thrush), as well as ED visits or hospitalizations attributable to asthma. Parents were sent information regarding adverse events at the beginning of each school year and were asked to call study personnel if such events occurred. In addition, parents were interviewed by telephone 3 times during the study period.
Outcome Variables
The primary hypothesis was that the supervised asthma therapy group would have a smaller proportion of children experiencing an EPAC each month, compared with the usual-care group. An EPAC was defined as Ն1 of the following each month: (1) an absence from school attributable to respiratory illness/asthma; (2) average use of rescue medication Ͼ2 times per week (not including preexercise treatment); or (3) Ն1 red or yellow PFM reading.
Sample Size
A sample size of 100 children per group was calculated to have a minimum of 80% power to detect a 10% timeaveraged difference in the proportions of EPACs between the groups (2-sided ␣ of .05). 35 We assumed a correlation no greater than 0.25 among a child's outcomes and adjusted for seasonality in the rate of EPACs.
Statistical Analyses
The primary hypothesis was tested in 2 ways. A 2 test was used to examine the difference in the probabilities of experiencing EPACs between the 2 groups for each individual month, as well as the probabilities of experiencing EPACs in the baseline and follow-up periods. Generalized estimating equations were fitted in which the outcome indicated whether each individual experienced an EPAC in each month of the study period. We examined the interaction between the intervention and period (baseline or follow-up period) to assess whether the effect of the intervention differed according to period. Primary analyses considered the complete definition of an EPAC, whereas secondary analyses considered each of the 3 components of the definition of an EPAC individually.
RESULTS
Four hundred sixty children were assessed for eligibility (Fig 1) , 295 were eligible (97% of those considered ineligible were not enrolled in the targeted schools), and 290 were assigned randomly. Attrition was primarily (98%) attributable to children transferring to a nonparticipating school. There was no significant difference between treatment groups in attrition rates (P ϭ .26). After randomization, children who discontinued use of budesonide in accordance with their physicians' orders continued providing daily data.
The demographic and asthma characteristics of children randomly assigned are shown in Table 1 . There were no significant differences between the supervisedtherapy and usual-care groups in any of the demographic or asthma characteristics. Children had an average age of 11 years, were 57% male, and were primarily black (91%). Seventy-nine percent of children had moderate persistent asthma, but only 14% had rescue medication at school before the study. During the baseline period, there was no difference between the 2 treatment groups in the proportions of expected budesonide refills that were filled (supervised therapy, 57.3%; usual care, 54.2%; P ϭ .40). Because medication was administered daily by the study staff members to the children in the supervised-therapy group, we induced a high level of adherence among those children. However, the average adherence over the entire study period in the usual-care group was 38% (SD: 25%). Furthermore, 78% of children in the usual-care group were Յ50% adherent, which indicates that the distribution of adherence was both highly variable and highly skewed.
The Internet-based data-collection system allowed us to collect high-quality data with very few missing reports. 36 During the study period, a total of 26 417 daily reports were expected from the teachers and children. These daily reports provided information on PFM readings, asthma symptoms, and absences. Of the observed reports, 25 744 (97.5%) provided data regarding asthma control. No adverse events related to the study drug were reported.
There were no differences in the likelihoods of experiencing an EPAC in the baseline and follow-up periods for the usual-care group (P ϭ .94). For the supervisedtherapy group, however, the odds of experiencing an EPAC during the baseline period were 1.57 times the odds of experiencing an EPAC during the follow-up period (90% confidence interval [CI]: 1.20 -2.06; P ϭ .006). Figure 2 shows the decreases in proportions of children experiencing an EPAC from the baseline period to the follow-up period according to treatment group, and Fig 3 shows the proportions of children experiencing an EPAC each month according to treatment group. Table 2 shows the results of the univariate analyses according to month. Higher rates of EPACs were reported for the supervised-therapy group compared with the usual-care group in November (not statistically significant) and December (P ϭ .04) of the baseline period.
Generalized estimating equation modeling revealed a marginally significant interaction between intervention and time period (P ϭ .065) indicating that children in the supervised-therapy group showed greater improvement in asthma control from the baseline period to the 
FIGURE 1
Flow of participants through the study.
follow-up period than did children in the usual-care group. The odds of experiencing an EPAC among those in the supervised-therapy group during the baseline period were significantly higher (odds ratio: 1.38 [90% CI: 1.03-1.87]) than the odds among those in the usual-care group during the same period; whereas, the odds of experiencing an EPAC during the follow-up period among those in the supervised-therapy group were lower (odds ratio: 0.89 [90% CI: 0.64 -1.22]) than the odds among those in the usual-care group during the baseline period. For the individual components of the EPAC definition, there were no significant differences in either the interaction between or the main effects of treatment or time period (tests of interaction: PFM readings, P ϭ .20; absences attributable to respiratory illness, P ϭ .62; rescue medication use, P ϭ .11). There were no observed relationships between age (P ϭ .13), gender (P ϭ .18), or race (P ϭ .24) and the frequency of EPACs, and the relationship between the intervention and the frequency of EPACs was not modified with inclusion of any of these covariates in the model. There was a significant relationship between school system (P ϭ .08) and the frequency with which EPACs occurred; however, these differences did not modify the observed relationship between the intervention and the frequency of EPACs. There also were significant relationships between treatment and the likelihood of EPACs among specific subgroups of smoke exposure at baseline and ED visits and hospitalizations (Figs 4 and 5) . The magnitude of the interaction was increased for those exposed to smoke in the household compared with the entire cohort. The P value for the interaction in this group was .0997, which suggests that, among those exposed to smoke in the household, there was a difference in the frequencies of EPACs between the usual-care and supervised-therapy groups. Among children who either were not exposed to smoke at baseline or were exposed outside the household only, however, there was no evidence of a treatment effect. Among children who reported, at baseline, no ED visits or overnight hospitalizations during the previous 12 months, there was a large difference in the effect of the intervention (P ϭ .0057 for interaction). Among children who reported Ն1 ED visit or overnight hospitalization, however, no differences in treatment were seen, either according to year (ie, no interaction) or overall. In these secondary analyses, subgroups had small samples; therefore, we lacked power to detect important differences in these groups. Figure 6 shows the baseline and postintervention quality-of-life scores for both treatment groups. Significant increases in quality of life were seen in overall scores, as well as all domains, for both treatment groups. There were no significant differences between the groups.
DISCUSSION
Our findings are consistent with 2 small studies that indicated that supervised asthma therapy improved asthma control among urban schoolchildren. Inhaled corticosteroid treatment offers significant protection against asthma exacerbations, 1-5 but rates of adherence are low for these medications. 6, 7 Self-management education theories 37 suggest that adherence to daily medication use must become habit. Although few schools have school-based health clinics and many do not have full-time school nurses, ϳ5% of children receive medications at school on a typical day. 38 Rescue medications for asthma and medications for attention-deficit/hyperactivity disorder are most common. [38] [39] [40] [41] In this research study, we used 7 personnel in the 36 schools. The personnel not only supervised daily medication use but also conducted quality control on data-collection procedures and monitored adverse events. In many of our local school systems, medication supervision responsibilities lie with office personnel. These personnel have been trained and are supervising medication administration successfully. Therefore, it is feasible that even schools without nurses could implement supervised asthma therapy to ensure adherence for asthma controller medications. Once-daily dosing of inhaled budesonide is as effective as twice-daily dosing 27, [29] [30] [31] and was used in this trial to facilitate adherence and implementation of the intervention. This aspect of the intervention increases the feasibility of implementing supervised asthma therapy in a school setting. The test of interaction for this study yielded marginally significant results. In certain contexts, however, it has been recommended that tests of interaction be evaluated at the P ϭ .10 level. 42 Whether the interaction was evaluated at the P ϭ .05 or P ϭ .10 level, the results indicated an intervention effect. There are several possible reasons why the effect observed was not large. To collect quality data for this study, substantial intervention for the usual-care group was necessary. Children in both treatment groups received an Internet-based (26) 30 (21) 16 (11) 12 (10) 19 (16) 22 (19) Supervised therapy, n (%)
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FIGURE 4
Changes in proportions of children experiencing an EPAC from baseline to intervention according to secondhand smoke exposure and treatment group. a P ϭ .0997; b not significant. 
FIGURE 6
Mean changes in quality-of-life overall and subscale scores according to treatment group. Changes greater than 0 indicate improvement. All P values for within-group changes were Ͻ.05; all P values for between-group changes were Ͼ.05.
asthma education program, as well as daily monitoring of symptoms and PFM readings. Other investigators reported improvement in asthma symptoms among children who monitored their asthma. 43 Recording of behavior sensitizes an individual to that behavior thereby facilitating behavior change. 44 It is likely that the monitoring system increased sensitivity to the children's asthma, and it might have served as a cue for the children to take their rescue medications or to engage in behaviors to decrease exposure to asthma triggers. Furthermore, inhaled steroids were provided to both treatment groups at no cost to the families and obtaining refills was simplified, thereby removing financial and access barriers to adherence 45 for the usual-care group. Adherence rates were low for both groups during the baseline period (Table 1 ) and for the usual-care group throughout the study. Despite the elimination of financial and access barriers, the average adherence rate over the entire study period for the usual-care group was 38% (SD: 25%), similar to that found in a large Centers for Disease Control and Prevention-funded trial with inner-city children. 46 This suggests that there are additional barriers to medication adherence in this predominantly black urban population. Reports have described such barriers in inner-city populations, including beliefs related to medications 45, [47] [48] [49] [50] [51] [52] [53] and the belief that asthma is an episodic disease that requires only episodic medication administration. 54 Both groups of children were provided with rescue medication at no cost to ensure their safety as well as our ability to monitor rescue medication use at school. Before the start of this study, only 14% of children had rescue medication at school.
There was not a true control group, because intervention occurred in both groups. This most likely biased our results toward no difference between groups. In a previous study investigating the impact of providing lowdose inhaled corticosteroids at school or at home, Millard et al 24 found that provision of inhaled steroids without school supervision improved asthma control, compared with usual care, but not as much as schoolbased administration of steroids. In addition to the aforementioned issues, other changes in behavior that often occur simply as a result of being involved in a clinical trial also might have led to positive effects in the usualcare group. Not surprisingly, significant improvement in quality of life was seen in both treatment groups but there was no difference between the groups, which further indicates that the usual-care group might not have been a true control group.
Three additional points should be considered when these results are being interpreted. First, medication use was supervised only on school days. Medication use was not supervised on weekends, on school holidays, during the summer, or when the child was absent for the entire school day. Children in the supervised-therapy group were provided with budesonide inhalation powder for use at home, but it is not known how commonly it was used on those days. Improvements in asthma control were seen in this group which might indicate that children in the supervised-therapy group were more likely to take their medication at home because they were acquiring the daily habit at school or that provision of inhaled steroids at a "less than perfect" adherence rate still improved asthma control. 55 Second, children in the supervised-therapy group experienced a higher rate of EPACs at baseline than did children in the usual-care group. Because randomization occurred after baseline data collection and children assigned randomly to the supervised-therapy group experienced higher rates of EPACs during the baseline period, our analyses were biased toward the null hypothesis, which could account for the small observed effect. Third, it is important to acknowledge that use of the time period from October to December misses the "back-to-school" outbreaks of asthma symptoms described in the literature. 20, 21, 56 Logistic issues involved in implementing the Asthma Agents system in 36 schools in 5 school systems at the beginning of the school year prevented us from implementing the system in all schools until the end of September.
Secondary analyses suggested that certain subgroups of children benefited more from supervised therapy. The intervention seemed to have greater effects among children who were exposed to secondhand smoke at home and those who reported no ED visits or overnight hospitalizations in the previous year at baseline. The results concerning secondhand smoke conflicted with those reported by Halterman et al, 22 who found that supervised asthma therapy was effective in improving the number of symptom-free days only among children who were not exposed to secondhand smoke. Relatively small numbers in both our study and the study by Halterman et al 22 indicate that more research is needed in this area. In addition, there is variability in clinical responses to inhaled corticosteroids, and data suggest that black children who have poor asthma control have increased risk for corticosteroid insensitivity. 57, 58 Therefore, there might be a biological basis for why the intervention did not work as well for children who had ED visits or hospitalizations. Sample sizes in those subgroups were small, however, and results must be interpreted with caution.
CONCLUSIONS
The justification for supervised therapy is based on the benefit that can be achieved by decreasing asthma morbidity. Once-daily supervised asthma therapy is a simple intervention that improves asthma control. Clinicians who have pediatric patients with asthma with poor outcomes that are possibly attributable to medication nonadherence should consider coordinating supervised therapy with the parent and the child's school. Because medication administration at school is common, this is a reasonable approach for reducing asthma morbidity. There are federal and state guidelines for taking medications in school, and each school district may have its own policies and mechanisms. 59 Physicians should be familiar with state and local policies and the forms required for medication use in school. In the absence of established policies, physicians may need to work with the school or parents to establish a protocol. 60 Furthermore, many schools do not have full-time nurses; there-fore, physicians may want to work with other school personnel, to train them to supervise inhaled steroid use among children.
